{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:20:50Z","timestamp":1792714850932,"version":"4.5.0"},"reference-count":263,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T00:00:00Z","timestamp":1409270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000902","name":"European Union","doi-asserted-by":"publisher","award":["NMP3-SME-2013-604531"],"award-info":[{"award-number":["NMP3-SME-2013-604531"]}],"id":[{"id":"10.13039\/501100000902","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.addr.2014.08.006","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T04:21:43Z","timestamp":1409113303000},"page":"85-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"special_numbering":"C","title":["Drug and cell delivery for cardiac regeneration"],"prefix":"10.1016","volume":"84","author":[{"given":"Conn L.","family":"Hastings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen T.","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ruiz-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Schenke-Layland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry P.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2014.08.006_bb0005","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","article-title":"Pathological ventricular remodeling: mechanisms: part 1 of 2","volume":"128","author":"Burchfield","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0010","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1039\/c0jm00805b","article-title":"Multimodal biomaterial strategies for regeneration of infarcted myocardium","volume":"20","author":"Mukherjee","year":"2010","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.addr.2014.08.006_bb0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1387\/ijdb.103219ct","article-title":"Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy \u2014 current status and future developments","volume":"55","author":"Templin","year":"2011","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.addr.2014.08.006_bb0020","doi-asserted-by":"crossref","first-page":"173ra25","DOI":"10.1126\/scitranslmed.3005503","article-title":"Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction","volume":"5","author":"Seif-Naraghi","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0025","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.addr.2014.08.006_bb0030","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","article-title":"Heart disease and stroke statistics \u2014 2013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rsif.2011.0301","article-title":"Biomaterial strategies for alleviation of myocardial infarction","volume":"9","author":"Venugopal","year":"2012","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.addr.2014.08.006_bb0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2014.08.006_bb0045","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1161\/01.CIR.0000106684.71725.98","article-title":"Selecting the best reperfusion strategy in ST-elevation myocardial infarction: it's all a matter of time","volume":"108","author":"Giugliano","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0050","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.addr.2014.08.006_bb0055","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.1073\/pnas.181177898","article-title":"Mobilized bone marrow cells repair the infarcted heart, improving function and survival","volume":"98","author":"Orlic","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2014.08.006_bb0060","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-2828(03)00211-6","article-title":"Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart","volume":"35","author":"Kudo","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0065","doi-asserted-by":"crossref","first-page":"II247","DOI":"10.1161\/01.CIR.100.suppl_2.II-247","article-title":"Autologous transplantation of bone marrow cells improves damaged heart function","volume":"100","author":"Tomita","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0070","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejcts.2006.02.070","article-title":"Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion","volume":"30","author":"Tang","year":"2006","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.RES.0000151843.79801.60","article-title":"Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion","volume":"96","author":"Kajstura","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb0080","doi-asserted-by":"crossref","first-page":"17783","DOI":"10.1073\/pnas.0706406104","article-title":"Bone marrow cells adopt the cardiomyogenic fate in vivo","volume":"104","author":"Rota","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2014.08.006_bb0085","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.lfs.2003.10.035","article-title":"Long-term effects of bone marrow mononuclear cell transplantation on left ventricular function and remodeling in rats","volume":"74","author":"Zhang","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2014.08.006_bb0090","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/hc3501.093817","article-title":"Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines","volume":"104","author":"Kamihata","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.regpep.2003.09.005","article-title":"Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium","volume":"117","author":"Tang","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.addr.2014.08.006_bb0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/01.CIR.0000151812.86142.45","article-title":"Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model","volume":"111","author":"Silva","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00029330-200702020-00009","article-title":"Transplantation of autologous adipose-derived stem cells ameliorates cardiac function in rabbits with myocardial infarction","volume":"120","author":"Zhang","year":"2007","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.addr.2014.08.006_bb0110","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature02446","article-title":"Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts","volume":"428","author":"Murry","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.addr.2014.08.006_bb0115","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1161\/01.CIR.0000043246.74879.CD","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)","volume":"106","author":"Assmus","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0120","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa060186","article-title":"Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction","volume":"355","author":"Sch\u00e4chinger","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0125","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial","volume":"113","author":"Meyer","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0130","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/eurheartj\/ehn436","article-title":"Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction","author":"Huikuri","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.addr.2014.08.006_bb0135","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00392-011-0327-y","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy","volume":"100","author":"Leistner","year":"2011","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0140","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1093\/eurheartj\/ehp374","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial","volume":"30","author":"Meyer","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.addr.2014.08.006_bb0145","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa055706","article-title":"Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction","volume":"355","author":"Lunde","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0150","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/eurheartj\/ehq455","article-title":"Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial","volume":"32","author":"Roncalli","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.addr.2014.08.006_bb0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(05)67861-0","article-title":"Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial","volume":"367","author":"Janssens","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2014.08.006_bb0160","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/eurheartj\/ehq449","volume":"32","author":"Hirsch","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.addr.2014.08.006_bb0165","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction","volume":"54","author":"Hare","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0170","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2014.08.006_bb0175","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.2011.1670","article-title":"Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial","volume":"306","author":"Traverse","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2014.08.006_bb0180","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2014.08.006_bb0185","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJMoa051779","article-title":"Transcoronary transplantation of progenitor cells after myocardial infarction","volume":"355","author":"Assmus","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0190","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacc.2010.03.066","article-title":"Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction","volume":"56","author":"Behfar","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0195","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1096\/fj.05-5211com","article-title":"Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement","volume":"20","author":"Gnecchi","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2014.08.006_bb0200","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","article-title":"Paracrine mechanisms in adult stem cell signaling and therapy","volume":"103","author":"Gnecchi","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bmb\/ldr018","article-title":"Cardiac cell therapy: where we've been, where we are, and where we should be headed","author":"Malliaras","year":"2011","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.addr.2014.08.006_bb0210","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1172\/JCI200522326","article-title":"Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction","volume":"115","author":"Yoon","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2014.08.006_bb0215","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2014.08.006_bb0220","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/eurheartj\/ehm426","article-title":"Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction","volume":"28","author":"Valina","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.addr.2014.08.006_bb0225","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2011.09.065","article-title":"First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction","volume":"59","author":"Houtgraaf","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0230","first-page":"A17966","article-title":"First in man transendocardial injection of autologous adipose-derived stem cells in patients with non revascularizable ischemic myocardium (PRECISE) (Abstract)","author":"Perin","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/rme.12.17","article-title":"Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design","volume":"7","author":"Qayyum","year":"2012","journal-title":"Regen. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0240","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/nm912","article-title":"Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts","volume":"9","author":"Mangi","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0245","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","article-title":"Intramyocardial, autologous CD34+ cell therapy for refractory angina","volume":"109","author":"Losordo","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb0250","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/CIRCULATIONAHA.106.687376","article-title":"Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I\/IIa double-blind, randomized controlled trial","volume":"115","author":"Losordo","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0255","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2009.685","article-title":"Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial","volume":"301","author":"van Ramshorst","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2014.08.006_bb0260","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1161\/CIRCULATIONAHA.112.000230","article-title":"Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy","volume":"128","author":"Vrtovec","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0003-4975(95)00374-6","article-title":"Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation","volume":"60","author":"Chiu","year":"1995","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0270","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nm0898-929","article-title":"Regenerating functional myocardium: improved performance after skeletal myoblast transplantation","volume":"4","author":"Taylor","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0275","doi-asserted-by":"crossref","first-page":"I223","DOI":"10.1161\/hc37t1.094593","article-title":"Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors?","volume":"104","author":"Pouzet","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0280","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/01.CIR.103.14.1920","article-title":"Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction","volume":"103","author":"Jain","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0285","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1067\/mtc.2001.112937","article-title":"Cellular therapy reverses myocardial dysfunction","volume":"121","author":"Rajnoch","year":"2001","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0290","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1172\/JCI119070","article-title":"Skeletal myoblast transplantation for repair of myocardial necrosis","volume":"98","author":"Murry","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2014.08.006_bb0295","first-page":"119","article-title":"Myocardial regeneration. Transplanting satellite cells into damaged myocardium","volume":"22","author":"Yoon","year":"1995","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.addr.2014.08.006_bb0300","doi-asserted-by":"crossref","first-page":"I131","DOI":"10.1161\/01.cir.0000032889.55215.f1","article-title":"Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction","volume":"106","author":"Ghostine","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0305","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(03)00092-5","article-title":"Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction","volume":"41","author":"Menasch\u00e9","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0310","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"Menasch\u00e9","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0315","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/jmcc.2001.1507","article-title":"Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting","volume":"34","author":"Reinecke","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0320","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1054-8807(00)00055-7","article-title":"Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing?","volume":"9","author":"Reinecke","year":"2000","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.addr.2014.08.006_bb0325","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ymthe.2005.07.686","article-title":"Differential myocardial infarct repair with muscle stem cells compared to myoblasts","volume":"12","author":"Oshima","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2014.08.006_bb0330","doi-asserted-by":"crossref","first-page":"V143","DOI":"10.1055\/s-0030-1269167","article-title":"Cardiogenic progenitor cells derived from skeletal muscle \u2014 a promising autologous cell source for cardiac cell therapy","volume":"59","author":"Choi","year":"2011","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0335","first-page":"611","article-title":"MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases","volume":"10","author":"Haider","year":"2008","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.addr.2014.08.006_bb0340","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.jacc.2003.06.017","article-title":"Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up","volume":"42","author":"Smits","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0345","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1038\/ncpcardio0416","article-title":"Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure\u2013volume loops","volume":"S1","author":"Steendijk","year":"2006","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0350","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1583\/04-1386R.1","article-title":"Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction","volume":"11","author":"Ince","year":"2004","journal-title":"J. Endovasc. Ther."},{"key":"10.1016\/j.addr.2014.08.006_bb0355","first-page":"417","article-title":"Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients","volume":"1","author":"Smits","year":"2006","journal-title":"EuroIntervention"},{"key":"10.1016\/j.addr.2014.08.006_bb0360","doi-asserted-by":"crossref","first-page":"11384","DOI":"10.1074\/jbc.M310822200","article-title":"Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes","volume":"279","author":"Matsuura","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2014.08.006_bb0365","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1073\/pnas.0706760104","article-title":"Human cardiac stem cells","volume":"104","author":"Bearzi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2014.08.006_bb0370","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.RES.0000147315.71699.51","article-title":"Isolation and expansion of adult cardiac stem cells from human and murine heart","volume":"95","author":"Messina","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb0375","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pcad.2007.03.004","article-title":"Advances in cell-based therapy for structural heart disease","volume":"49","author":"Mazhari","year":"2007","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.addr.2014.08.006_bb0380","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajpath.2011.03.036","article-title":"Effects of age and heart failure on human cardiac stem cell function","volume":"179","author":"Cesselli","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2014.08.006_bb0385","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cell.2013.07.039","article-title":"Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair","volume":"154","author":"Ellison","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.addr.2014.08.006_bb0390","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","article-title":"Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial","volume":"378","author":"Bolli","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2014.08.006_bb0395","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1161\/CIRCULATIONAHA.112.092627","article-title":"Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance","volume":"126","author":"Chugh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0400","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13309","article-title":"c-kit+ cells minimally contribute cardiomyocytes to the heart","volume":"509","author":"van Berlo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.addr.2014.08.006_bb0405","doi-asserted-by":"crossref","first-page":"13380","DOI":"10.1073\/pnas.1208114109","article-title":"c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart","volume":"109","author":"Jesty","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.addr.2014.08.006_bb0410","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/stem.1696","article-title":"Concise review: the role of C-kit expressing cells in heart repair at the neonatal and adult stage","volume":"32","author":"Hesse","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.addr.2014.08.006_bb0415","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2014.08.006_bb0420","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","article-title":"Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice","volume":"106","author":"Chimenti","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb0425","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/01.CIR.0000068356.38592.68","article-title":"Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells","volume":"107","author":"Mummery","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0430","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2014.08.006_bb0435","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.20061916","article-title":"Cardiopoietic programming of embryonic stem cells for tumor-free heart repair","volume":"204","author":"Behfar","year":"2007","journal-title":"J. Exp. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2014.08.006_bb0440","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1038\/ncpcardio0429","article-title":"Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny","volume":"3","author":"Behfar","year":"2006","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0445","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","article-title":"Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics","volume":"61","author":"Bartunek","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0450","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/scrt403","article-title":"Extracellular matrix remodeling following myocardial infarction influences the therapeutic potential of mesenchymal stem cells","volume":"5","author":"Sullivan","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.addr.2014.08.006_bb0455","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12265-010-9202-x","article-title":"Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices","volume":"3","author":"Singelyn","year":"2010","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb0460","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nature10147","article-title":"Heart regeneration","volume":"473","author":"Laflamme","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.addr.2014.08.006_bb0465","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.yjmcc.2008.03.009","article-title":"Systems approaches to preventing transplanted cell death in cardiac repair","volume":"45","author":"Ashraf","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0470","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1582-4934.2011.01409.x","article-title":"Injectable biodegradable hydrogels for embryonic stem cell transplantation: improved cardiac remodelling and function of myocardial infarction","volume":"16","author":"Wang","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0475","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.athoracsur.2008.12.074","article-title":"Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison","volume":"87","author":"Hamdi","year":"2009","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0480","doi-asserted-by":"crossref","DOI":"10.4161\/biom.24490","article-title":"Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel","volume":"3","author":"Smith","year":"2013","journal-title":"Biomatter"},{"key":"10.1016\/j.addr.2014.08.006_bb0485","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1089\/ten.tea.2011.0591","article-title":"Hemodynamic contribution of stem cell scaffolding in acute injured myocardium","volume":"18","author":"Qian","year":"2012","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.addr.2014.08.006_bb0490","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.biomaterials.2011.12.044","article-title":"The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment","volume":"33","author":"Liu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0495","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1016\/j.biomaterials.2014.01.021","article-title":"Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0500","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.actbio.2009.04.040","article-title":"Bone marrow stem cells implantation with \u03b1-cyclodextrin\/MPEG\u2013PCL\u2013MPEG hydrogel improves cardiac function after myocardial infarction","volume":"5","author":"Wang","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2014.08.006_bb0505","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/107632704322791916","article-title":"A novel tubular scaffold for cardiovascular tissue engineering","volume":"10","author":"Yost","year":"2004","journal-title":"Tissue Eng."},{"key":"10.1016\/j.addr.2014.08.006_bb0510","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/01.ju.0000130466.84214.f7","article-title":"Shape retaining injectable hydrogels for minimally invasive bulking","volume":"172","author":"Thornton","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.addr.2014.08.006_bb0515","doi-asserted-by":"crossref","first-page":"19590","DOI":"10.1073\/pnas.1211516109","article-title":"Injectable preformed scaffolds with shape-memory properties","volume":"109","author":"Bencherif","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2014.08.006_bb0520","doi-asserted-by":"crossref","first-page":"111002","DOI":"10.1115\/1.3128729","article-title":"Bioprinting endothelial cells with alginate for 3D tissue constructs","volume":"131","author":"Khalil","year":"2009","journal-title":"J. Biomech. Eng."},{"key":"10.1016\/j.addr.2014.08.006_bb0525","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1089\/ten.tea.2007.0289","article-title":"Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix","volume":"14","author":"Zhang","year":"2008","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.addr.2014.08.006_bb0530","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1016\/j.biomaterials.2010.05.078","article-title":"The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat","volume":"31","author":"Yu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0535","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jacc.2004.04.040","article-title":"Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium","volume":"44","author":"Christman","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0540","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1016\/j.biomaterials.2011.06.049","article-title":"A combined cell therapy and in-situ tissue-engineering approach for myocardial repair","volume":"32","author":"Habib","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0545","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3727\/096368909788534915","article-title":"Percutaneous cell delivery into the heart using hydrogels polymerizing in situ","volume":"18","author":"Martens","year":"2009","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2014.08.006_bb0550","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1089\/ten.tea.2008.0143","article-title":"Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel","volume":"15","author":"Lu","year":"2009","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.addr.2014.08.006_bb0555","doi-asserted-by":"crossref","first-page":"III-56","DOI":"10.1161\/01.CIR.102.suppl_3.III-56","article-title":"Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?","volume":"102","author":"Leor","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0560","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/bit.10372","article-title":"Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds","volume":"80","author":"Dar","year":"2002","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.addr.2014.08.006_bb0565","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1634\/stemcells.2007-0132","article-title":"A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling","volume":"25","author":"Simpson","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.addr.2014.08.006_bb0570","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bit.23301","article-title":"Use of human embryonic stem cell derived-mesenchymal cells for cardiac repair","volume":"109","author":"Simpson","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.addr.2014.08.006_bb0575","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1083\/jcb.103.6.2637","article-title":"Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion","volume":"103","author":"Humphries","year":"1986","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2014.08.006_bb0580","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0142-9612(97)00185-3","article-title":"Microdistribution of substratum-bound ligands affects cell function: hepatocyte spreading on PEO-tethered galactose","volume":"19","author":"Griffith","year":"1998","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0585","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0142-9612(98)00107-0","article-title":"Alginate hydrogels as synthetic extracellular matrix materials","volume":"20","author":"Rowley","year":"1999","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0590","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1096\/fj.01-0826com","article-title":"Development of a hybrid cardiovascular graft using a tissue engineering approach","volume":"16","author":"Tiwari","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2014.08.006_bb0595","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/bit.10897","article-title":"Synthetic extracellular matrices for in situ tissue engineering","volume":"86","author":"Pratt","year":"2004","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.addr.2014.08.006_bb0600","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/01.RES.0000196562.73231.7d","article-title":"Engineering myocardial tissue","volume":"97","author":"Eschenhagen","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb0605","doi-asserted-by":"crossref","first-page":"I137","DOI":"10.1161\/01.cir.0000032893.55215.fc","article-title":"Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts","volume":"106","author":"Akhyari","year":"2002","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2014.08.006_bb0610","first-page":"I146","article-title":"3D engineered heart tissue for replacement therapy","volume":"97","author":"Eschenhagen","year":"2002","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0615","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0966-3274(02)00011-4","article-title":"Cardiac tissue engineering","volume":"9","author":"Eschenhagen","year":"2002","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.addr.2014.08.006_bb0620","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1010-7940(03)00577-3","article-title":"Bioartificial grafts for transmural myocardial restoration: a new cardiovascular tissue culture concept","volume":"24","author":"Kofidis","year":"2003","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0625","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1010-7940(02)00256-7","article-title":"A novel bioartificial myocardial tissue and its prospective use in cardiac surgery","volume":"22","author":"Kofidis","year":"2002","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0630","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1067\/mtc.2002.121971","article-title":"In vitro engineering of heart muscle: artificial myocardial tissue","volume":"124","author":"Kofidis","year":"2002","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0635","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm1394","article-title":"Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts","volume":"12","author":"Zimmermann","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0640","series-title":"Cardiac Grafting of Engineered Heart Tissue in Syngenic Rats","author":"Zimmermann","year":"2002"},{"key":"10.1016\/j.addr.2014.08.006_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2014.02.030","article-title":"Stem cell-loaded nanofibrous patch promotes the regeneration of infarcted myocardium with functional improvement in rat model","author":"Kai","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2014.08.006_bb0650","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.2012.06519.x","article-title":"A bird's-eye view of cell therapy and tissue engineering for cardiac regeneration","volume":"1254","author":"Soler-Botija","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2014.08.006_bb0655","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nmeth.2524","article-title":"Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Nunes","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.addr.2014.08.006_bb0660","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehn456","article-title":"Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction","volume":"29","author":"Korf-Klingebiel","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.addr.2014.08.006_bb0665","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1016\/j.biomaterials.2014.01.075","article-title":"Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury","volume":"35","author":"Russo","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_rf0605","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0735-1097(02)02121-6","article-title":"Extension of borderzone myocardium in postinfarction dilated cardiomyopathy","volume":"40","author":"Jackson","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_or0070","unstructured":"discussion 1168-71."},{"key":"10.1016\/j.addr.2014.08.006_bb0675","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0039-6109(03)00216-0","article-title":"The potential role of ventricular compressive therapy","volume":"84","author":"Gorman","year":"2004","journal-title":"Surg. Clin. N. Am."},{"key":"10.1016\/j.addr.2014.08.006_bb0680","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.100.9.999","article-title":"Mechanisms and models in heart failure: a combinatorial approach","volume":"100","author":"Mann","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0685","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa0900559","article-title":"Coronary bypass surgery with or without surgical ventricular reconstruction","volume":"360","author":"Jones","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0690","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/stcs.2001.29966","article-title":"Left ventricular reconstruction by endoventricular circular patch plasty repair: a 17-year experience","volume":"13","author":"Dor","year":"2001","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0695","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0003-4975(97)00779-0","article-title":"Partial left ventriculectomy to treat end-stage heart disease","volume":"64","author":"Batista","year":"1997","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0700","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.athoracsur.2007.03.095","article-title":"Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy","volume":"84","author":"Mann","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0705","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0003-4975(00)01755-0","article-title":"Passive epicardial containment prevents ventricular remodeling in heart failure","volume":"70","author":"Chaudhry","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0710","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1053\/j.semtcvs.2005.09.006","article-title":"Experimental and clinical studies with the Paracor cardiac restraint device","volume":"17","author":"Magovern","year":"2005","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0715","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jacc.2010.06.051","article-title":"Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve)","volume":"56","author":"Grossi","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0720","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.106.657270","article-title":"Theoretical impact of the injection of material into the myocardium: a finite element model simulation","volume":"114","author":"Wall","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0725","doi-asserted-by":"crossref","first-page":"9048","DOI":"10.1016\/j.biomaterials.2013.08.017","article-title":"The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction","volume":"34","author":"Serpooshan","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0730","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.1073\/pnas.1004097107","article-title":"Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model","volume":"107","author":"Ifkovits","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2014.08.006_bb0735","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/107632704323061762","article-title":"Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction","volume":"10","author":"Christman","year":"2004","journal-title":"Tissue Eng."},{"key":"10.1016\/j.addr.2014.08.006_bb0740","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/CIRCULATIONAHA.107.727420","article-title":"Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat","volume":"117","author":"Landa","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0745","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2009.06.010","article-title":"Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine","volume":"54","author":"Leor","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0750","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.biomaterials.2008.09.018","article-title":"The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction","volume":"30","author":"Tsur-Gang","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0755","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.biomaterials.2008.09.059","article-title":"The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model","volume":"30","author":"Yu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0760","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jacc.2005.04.056","article-title":"Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction","volume":"46","author":"Dai","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0765","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jbm.b.31386","article-title":"Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel","volume":"91","author":"Yoon","year":"2009","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.addr.2014.08.006_bb0770","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0022-5223(04)00836-0","article-title":"Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle","volume":"128","author":"Kofidis","year":"2004","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0775","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cardfail.2009.03.003","article-title":"A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling","volume":"15","author":"Dobner","year":"2009","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.addr.2014.08.006_bb0780","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/jbm.a.32118","article-title":"Injection of a novel synthetic hydrogel preserves left ventricle function after myocardial infarction","volume":"90","author":"Jiang","year":"2009","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2014.08.006_bb0785","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.biomaterials.2009.04.033","article-title":"The inhibition of postinfarct ventricle remodeling without polycythaemia following local sustained intramyocardial delivery of erythropoietin within a supramolecular hydrogel","volume":"30","author":"Wang","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0790","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1016\/j.biomaterials.2009.04.055","article-title":"Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium","volume":"30","author":"Fujimoto","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0795","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/eurjhf\/hfn009","article-title":"Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling","volume":"11","author":"Wang","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.addr.2014.08.006_bb0800","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.athoracsur.2008.04.107","article-title":"Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs","volume":"86","author":"Mukherjee","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0805","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.athoracsur.2011.04.051","article-title":"Modification of infarct material properties limits adverse ventricular remodeling","volume":"92","author":"Morita","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0810","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.athoracsur.2008.09.028","article-title":"Dermal filler injection: a novel approach for limiting infarct expansion","volume":"87","author":"Ryan","year":"2009","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0815","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.jacc.2007.02.050","article-title":"An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction","volume":"49","author":"Fujimoto","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0820","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.ijcard.2013.01.003","article-title":"Algisyl-LVR\u2122 with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart","volume":"168","author":"Lee","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0825","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12265-011-9291-1","article-title":"Injectable acellular hydrogels for cardiac repair","volume":"4","author":"Tous","year":"2011","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb0830","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1089\/ten.2005.11.1860","article-title":"Injectable biopolymers enhance angiogenesis after myocardial infarction","volume":"11","author":"Huang","year":"2005","journal-title":"Tissue Eng."},{"key":"10.1016\/j.addr.2014.08.006_bb0835","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jtcvs.2008.08.036","article-title":"Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy","volume":"137","author":"Yu","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2010.06.039","article-title":"Intra-myocardial biomaterial injection therapy in the treatment of heart failure: materials, outcomes and challenges","volume":"7","author":"Nelson","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2014.08.006_bb0845","first-page":"683","article-title":"Cardiac regeneration: current therapies \u2014 future concepts","volume":"5","author":"Doppler","year":"2013","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.addr.2014.08.006_bb0850","doi-asserted-by":"crossref","first-page":"18129","DOI":"10.1073\/pnas.0407817101","article-title":"Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds","volume":"101","author":"Radisic","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2014.08.006_bb0855","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-bioeng-071910-124701","article-title":"Bioengineering heart muscle: a paradigm for regenerative medicine","volume":"13","author":"Vunjak-Novakovic","year":"2011","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.addr.2014.08.006_bb0860","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1021\/cb3003368","article-title":"Reawakening atlas: chemical approaches to repair or replace dysfunctional musculature","volume":"7","author":"Jung","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.addr.2014.08.006_bb0865","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/emmm.201303687","article-title":"Prostaglandin E2 promotes post-infarction cardiomyocyte replenishment by endogenous stem cells","volume":"6","author":"Hsueh","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb0870","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.jtcvs.2013.02.045","article-title":"Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart","volume":"146","author":"Ishimaru","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb0875","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/CS20060301","article-title":"A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischaemic heart","volume":"112","author":"Nakamura","year":"2007","journal-title":"Clin. Sci."},{"key":"10.1016\/j.addr.2014.08.006_bb0880","doi-asserted-by":"crossref","first-page":"e79374","DOI":"10.1371\/journal.pone.0079374","volume":"8","author":"Murakoshi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2014.08.006_bb0885","doi-asserted-by":"crossref","first-page":"e15521","DOI":"10.1371\/journal.pone.0015521","article-title":"Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling","volume":"5","author":"Saraswati","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2014.08.006_bb0890","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/CIRCRESAHA.114.302500","article-title":"c-Kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy","volume":"114","author":"Sanada","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb0895","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2009.02.013","article-title":"Synergy between CD26\/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction","volume":"4","author":"Zaruba","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2014.08.006_bb0900","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.scr.2011.05.003","article-title":"Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1\/CXCR4 axis","volume":"7","author":"Theiss","year":"2011","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.addr.2014.08.006_bb0905","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijcard.2009.09.555","article-title":"Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial) \u2014 rationale, design and first interim analysis","volume":"145","author":"Theiss","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb0910","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nbt.1733","article-title":"Expression of therapeutic proteins after delivery of chemically modified mRNA in mice","volume":"29","author":"Kormann","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2014.08.006_bb0915","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2014.08.006_bb0920","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/mthe.2000.0053","article-title":"Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo","volume":"1","author":"Armeanu","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2014.08.006_bb0925","doi-asserted-by":"crossref","DOI":"10.1021\/bm401878p","article-title":"Polymer\u2013peptide delivery platforms: effect of oligopeptide orientation on polymer-based DNA delivery","author":"Parelkar","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2014.08.006_bb0930","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nbt.2682","article-title":"Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction","volume":"31","author":"Zangi","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2014.08.006_bb0935","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/ATVBAHA.112.300137","article-title":"MicroRNAs in myocardial infarction","volume":"33","author":"Fiedler","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.addr.2014.08.006_bb0940","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature11739","article-title":"Functional screening identifies miRNAs inducing cardiac regeneration","volume":"492","author":"Eulalio","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.addr.2014.08.006_bb0945","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1174381","article-title":"MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice","volume":"324","author":"Bonauer","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.addr.2014.08.006_bb0950","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature11919","article-title":"MicroRNA-34a regulates cardiac ageing and function","volume":"495","author":"Boon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.addr.2014.08.006_bb0955","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1161\/CIRCULATIONAHA.109.928424","article-title":"MicroRNA-210 as a novel therapy for treatment of ischemic heart disease","volume":"122","author":"Hu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb0960","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1172\/JCI33483","article-title":"Chemical modification: the key to clinical application of RNA interference?","volume":"117","author":"Corey","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2014.08.006_bb0965","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","article-title":"Progress in microRNA delivery","volume":"172","author":"Zhang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2014.08.006_bb0970","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1517\/17425247.2013.798640","article-title":"Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics","volume":"10","author":"Muthiah","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2014.08.006_bb0975","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/10717544.2012.738436","article-title":"Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology","volume":"19","author":"Chistiakov","year":"2012","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2014.08.006_bb0980","doi-asserted-by":"crossref","DOI":"10.3233\/THC-130772","article-title":"Enhanced delivery of microRNA mimics to cardiomyocytes using ultrasound responsive microbubbles reverses hypertrophy in an in-vitro model","author":"Gill","year":"2014","journal-title":"Technol. Health Care"},{"key":"10.1016\/j.addr.2014.08.006_bb0985","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/mt.2013.288","article-title":"A collagen-based scaffold delivering exogenous microRNA-29B to modulate extracellular matrix remodeling","volume":"22","author":"Monaghan","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2014.08.006_bb0990","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1016\/j.biomaterials.2013.03.052","article-title":"The promotion of bone regeneration through positive regulation of angiogenic\u2013osteogenic coupling using microRNA-26a","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb0995","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.celrep.2014.01.038","article-title":"Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4","volume":"6","author":"Wang","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.addr.2014.08.006_bb1000","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.addr.2014.08.006_bb1005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature11044","article-title":"In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes","volume":"485","author":"Qian","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.addr.2014.08.006_bb1010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","article-title":"Heart repair by reprogramming non-myocytes with cardiac transcription factors","volume":"485","author":"Song","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.addr.2014.08.006_bb1015","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCRESAHA.112.269035","article-title":"MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes","volume":"110","author":"Jayawardena","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb1020","doi-asserted-by":"crossref","first-page":"a014050","DOI":"10.1101\/cshperspect.a014050","article-title":"Direct cardiomyocyte reprogramming: a new direction for cardiovascular regenerative medicine","volume":"3","author":"Yi","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb1025","doi-asserted-by":"crossref","DOI":"10.1002\/anie.201307034","article-title":"Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agents","author":"Plowright","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2014.08.006_bb1030","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1016\/j.biomaterials.2013.12.071","article-title":"Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction","volume":"35","author":"Pavo","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb1035","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.addr.2014.08.006_bb1040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12265-010-9207-5","article-title":"Protein therapeutics for cardiac regeneration after myocardial infarction","volume":"3","author":"Segers","year":"2010","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb1045","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1161\/CIRCULATIONAHA.107.718718","article-title":"Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction","volume":"116","author":"Segers","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb1050","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/CIRCULATIONAHA.111.070508","article-title":"The bispecific SDF1-GPVI fusion protein preserves myocardial function after transient ischemia in mice","volume":"125","author":"Ziegler","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb1055","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/CIRCRESAHA.111.300440","article-title":"An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure","volume":"112","author":"Penn","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb1060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/eurjhf\/hfq152","article-title":"Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses","volume":"13","author":"Jabbour","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.addr.2014.08.006_bb1065","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/nm1619","article-title":"Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair","volume":"13","author":"Kuhn","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb1070","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1172\/JCI10226","article-title":"Myocardial protection from ischemia\/reperfusion injury by endogenous and exogenous HGF","volume":"106","author":"Nakamura","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2014.08.006_bb1075","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.RES.0000183733.53101.11","article-title":"Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival","volume":"97","author":"Urbanek","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb1080","series-title":"Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack","author":"Biomedica Corp","year":"2012"},{"key":"10.1016\/j.addr.2014.08.006_bb1085","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/01.RES.0000117306.10142.50","article-title":"Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression","volume":"94","author":"Torella","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb1090","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.0000027563.44593.CC","article-title":"Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case\u2013control study","volume":"106","author":"Juul","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb1095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCINTERVENTIONS.110.960765","article-title":"Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction","volume":"4","author":"O'Sullivan","year":"2011","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.addr.2014.08.006_bb1100","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.0602877103","article-title":"Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction","volume":"103","author":"Davis","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2014.08.006_bb1105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2013.04.022","article-title":"Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction","volume":"170","author":"Chang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2014.08.006_bb1110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2013.10.034","article-title":"Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration","volume":"173","author":"Formiga","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2014.08.006_bb1115","article-title":"Controlled delivery of sonic hedgehog morphogen and its potential for cardiac repair","volume":"8","author":"Johnson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2014.08.006_bb1120","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/89083","article-title":"The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors","volume":"7","author":"Pola","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb1125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jss.2004.12.025","article-title":"Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction","volume":"126","author":"Fujita","year":"2005","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb1130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.biomaterials.2010.08.098","article-title":"Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel","volume":"32","author":"Wu","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb1135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/adhm.201300076","article-title":"A fast pH-switchable and self-healing supramolecular hydrogel carrier for guided, local catheter injection in the infarcted myocardium","volume":"3","author":"Bastings","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2014.08.006_bb1140","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jacc.2011.05.013","article-title":"Endogenous cardiac stem cell activation by insulin-like growth factor-1\/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart","volume":"58","author":"Ellison","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb1145","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.biomaterials.2013.12.011","article-title":"Regeneration of chronic myocardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide Ac-SDKP","volume":"35","author":"Song","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb1150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2010.09.011","article-title":"SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction","volume":"129","author":"Ghadge","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.addr.2014.08.006_bb1155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ahj.2008.03.024","article-title":"Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials","volume":"156","author":"Abdel-Latif","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.addr.2014.08.006_bb1160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.biomaterials.2010.08.097","article-title":"The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction","volume":"32","author":"Ruvinov","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb1165","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/CIRCULATIONAHA.110.010264","article-title":"Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure","volume":"124","author":"Banquet","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb1170","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.12225","article-title":"Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction","author":"Projahn","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb1175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2143\/AC.60.3.2005005","article-title":"Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model","volume":"60","author":"Yoon","year":"2005","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb1180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/SHK.0b013e318289728a","article-title":"Treatment with bone morphogenetic protein 2 limits infarct size after myocardial infarction in mice","volume":"39","author":"Ebelt","year":"2013","journal-title":"Shock"},{"key":"10.1016\/j.addr.2014.08.006_bb1185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/emboj.2011.418","article-title":"Wnt1\/\u03b2catenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair","volume":"31","author":"Duan","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2014.08.006_bb1190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/cvr\/cvu054","article-title":"Cell\u2013cell interaction in the heart via Wnt\/\u03b2-catenin pathway after cardiac injury","volume":"102","author":"Deb","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2014.08.006_bb1195","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/eurheartj\/ehm177","article-title":"Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization","volume":"28","author":"Westenbrink","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.addr.2014.08.006_bb1200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00380-011-0197-2","article-title":"Effects of erythropoietin on angiogenesis after myocardial infarction in porcine","volume":"27","author":"Kawachi","year":"2012","journal-title":"Heart Vessels"},{"key":"10.1016\/j.addr.2014.08.006_bb1205","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijcard.2013.12.011","article-title":"Erythropoietin and the heart: physiological effects and the therapeutic perspective","volume":"171","author":"Sanchis-Gomar","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb1210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10557-013-6461-1","article-title":"What is the role of erythropoietin in acute myocardial infarct? Bridging the gap between experimental models and clinical trials","volume":"27","author":"Roubille","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.addr.2014.08.006_bb1215","doi-asserted-by":"crossref","first-page":"9201","DOI":"10.1016\/j.biomaterials.2013.08.007","article-title":"Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors","volume":"34","author":"Brudno","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.08.006_bb1220","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/ATVBAHA.110.207928","article-title":"Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization","volume":"30","author":"Saif","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.addr.2014.08.006_bb1225","first-page":"14990","article-title":"Prevascularization of cardiac patch on the omentum improves its therapeutic outcome","volume":"106","author":"Dvir","year":"2009"},{"key":"10.1016\/j.addr.2014.08.006_bb1230","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/CIRCULATIONAHA.109.852285","article-title":"Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction","volume":"120","author":"Padin-Iruegas","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb1235","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.jacc.2008.06.052","article-title":"Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction","volume":"52","author":"Takehara","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb1240","first-page":"5","article-title":"CADUCEUS, SCIPIO, ALCADIA: cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving","volume":"2013","author":"Yacoub","year":"2013","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"10.1016\/j.addr.2014.08.006_bb1245","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jtcvs.2013.05.035","article-title":"Impact of cardiac support device combined with slow-release prostacyclin agonist in a canine ischemic cardiomyopathy model","volume":"147","author":"Kubota","year":"2014","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb1250","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/ejcts\/ezs480","article-title":"Development of cardiac support bioprostheses for ventricular restoration and myocardial regeneration","volume":"43","author":"Shafy","year":"2013","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb1255","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/jama.2013.3527","article-title":"Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial","volume":"309","author":"Assmus","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2014.08.006_bb1260","first-page":"806795","article-title":"Development of bioartificial myocardium using stem cells and nanobiotechnology templates","volume":"2011","author":"Chachques","year":"2010","journal-title":"Cardiol. Res. Pract."},{"key":"10.1016\/j.addr.2014.08.006_bb1265","author":"US Food and Drug Administration"},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2014.08.006_bb1270","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1038\/ncpcardio0446","article-title":"Catheter-based delivery of cells to the heart","volume":"3","author":"Sherman","year":"2006","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb1275","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.mayocp.2013.10.020","article-title":"Emerging medical devices for minimally invasive cell therapy","volume":"89","author":"O'Cearbhaill","year":"2014","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.addr.2014.08.006_bb1280","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1540-8183.2007.00255.x","article-title":"MRI evaluation of local myocardial treatments: epicardial versus endocardial (Cell-Fix catheter) injections","volume":"20","author":"Chachques","year":"2007","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.addr.2014.08.006_bb1285","doi-asserted-by":"crossref","first-page":"I150","DOI":"10.1161\/CIRCULATIONAHA.104.526749","article-title":"Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials","volume":"112","author":"Hou","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2014.08.006_bb1290","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCINTERVENTIONS.112.000422","article-title":"Optimized delivery system achieves enhanced endomyocardial stem cell retention","volume":"6","author":"Behfar","year":"2013","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.addr.2014.08.006_bb1295","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1479-5876-9-12","article-title":"Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion","volume":"9","author":"Anastasiadis","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.addr.2014.08.006_bb1300","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00595-008-3803-x","article-title":"Combined autologous cellular cardiomyoplasty using skeletal myoblasts and bone marrow cells for human ischemic cardiomyopathy with left ventricular assist system implantation: report of a case","volume":"39","author":"Miyagawa","year":"2009","journal-title":"Surg. Today"},{"key":"10.1016\/j.addr.2014.08.006_bb1305","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.athoracsur.2006.06.074","article-title":"Cardiac resurrection after bone-marrow-derived mononuclear cell transplantation during left ventricular assist device support","volume":"83","author":"Gojo","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2014.08.006_bb1310","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3727\/096368907783338235","article-title":"Intramyocardial delivery of bone marrow mononuclear cells and mechanical assist device implantation in patients with end-stage cardiomyopathy","volume":"16","author":"Nasseri","year":"2007","journal-title":"Cell Transplant."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X1400180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X1400180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T17:13:55Z","timestamp":1650042835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X1400180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":263,"alternative-id":["S0169409X1400180X"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2014.08.006","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug and cell delivery for cardiac regeneration","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2014.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}